SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-17-008421
Filing Date
2017-11-06
Accepted
2017-11-06 16:06:32
Documents
59
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1702887-10q.htm 10-Q 703925
2 EXHIBIT 31.1 t1702887_ex31-1.htm EX-31.1 6697
3 EXHIBIT 31.2 t1702887_ex31-2.htm EX-31.2 6679
4 EXHIBIT 32.1 t1702887_ex32-1.htm EX-32.1 2799
5 EXHIBIT 32.2 t1702887_ex32-2.htm EX-32.2 2779
  Complete submission text file 0001571049-17-008421.txt   3538632

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pahc-20170930.xml EX-101.INS 691071
7 XBRL SCHEMA FILE pahc-20170930.xsd EX-101.SCH 31246
8 XBRL CALCULATION FILE pahc-20170930_cal.xml EX-101.CAL 49318
9 XBRL DEFINITION FILE pahc-20170930_def.xml EX-101.DEF 121143
10 XBRL LABEL FILE pahc-20170930_lab.xml EX-101.LAB 293695
11 XBRL PRESENTATION FILE pahc-20170930_pre.xml EX-101.PRE 216095
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 171179559
SIC: 2834 Pharmaceutical Preparations